EP1150669A4 - FORMULATIONS ON L-ARGININE BASE FOR DISEASE TREATMENT AND USE THEREOF - Google Patents
FORMULATIONS ON L-ARGININE BASE FOR DISEASE TREATMENT AND USE THEREOFInfo
- Publication number
- EP1150669A4 EP1150669A4 EP00911701A EP00911701A EP1150669A4 EP 1150669 A4 EP1150669 A4 EP 1150669A4 EP 00911701 A EP00911701 A EP 00911701A EP 00911701 A EP00911701 A EP 00911701A EP 1150669 A4 EP1150669 A4 EP 1150669A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- methods
- same
- treating diseases
- based formulations
- arginine based
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06007096A EP1671630A3 (en) | 1999-02-05 | 2000-02-04 | L-Arginine based formulations for treating diseases and methods of using the same |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11890399P | 1999-02-05 | 1999-02-05 | |
US118903P | 1999-02-05 | ||
PCT/US2000/002798 WO2000045809A1 (en) | 1999-02-05 | 2000-02-04 | L-arginine based formulations for treating diseases and methods of using same |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP06007096A Division EP1671630A3 (en) | 1999-02-05 | 2000-02-04 | L-Arginine based formulations for treating diseases and methods of using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1150669A1 EP1150669A1 (en) | 2001-11-07 |
EP1150669A4 true EP1150669A4 (en) | 2005-06-22 |
Family
ID=22381443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00911701A Withdrawn EP1150669A4 (en) | 1999-02-05 | 2000-02-04 | FORMULATIONS ON L-ARGININE BASE FOR DISEASE TREATMENT AND USE THEREOF |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1150669A4 (es) |
JP (1) | JP2002536325A (es) |
AU (1) | AU3356000A (es) |
CA (1) | CA2361575A1 (es) |
MX (1) | MXPA01007952A (es) |
WO (1) | WO2000045809A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6425881B1 (en) * | 1994-10-05 | 2002-07-30 | Nitrosystems, Inc. | Therapeutic mixture useful in inhibiting lesion formation after vascular injury |
US5968983A (en) | 1994-10-05 | 1999-10-19 | Nitrosystems, Inc | Method and formulation for treating vascular disease |
AU4013900A (en) | 1999-03-19 | 2000-10-09 | Enos Pharmaceuticals, Inc. | Increasing cerebral bioavailability of drugs |
JP5065570B2 (ja) * | 2002-09-06 | 2012-11-07 | 第一三共ヘルスケア株式会社 | 血管内皮性酸化窒素の合成促進剤 |
WO2005016400A1 (en) * | 2003-08-14 | 2005-02-24 | Blue Medical Devices B.V. | Endoluminal prosthesis comprising a therapeutic agent |
EP1591118A1 (en) * | 2004-04-27 | 2005-11-02 | Nutri-Fit GmbH & Co. KG | Use of melatonin in preventing postoperative complications |
JP2012041296A (ja) * | 2010-08-19 | 2012-03-01 | Medience Corp | 血管内皮機能改善剤、一酸化窒素産生促進剤、及び飲食品 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0745332A1 (en) * | 1995-06-01 | 1996-12-04 | N.V. Nutricia | Clinical nutritional composition |
WO1999062509A1 (en) * | 1998-06-01 | 1999-12-09 | Nitromed, Inc. | Endogenous nitric oxide synthesis under conditions of low oxygen tension |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4758569A (en) * | 1987-08-26 | 1988-07-19 | Pfizer Inc. | Doxazosin as an anti-atherosclerosis agent |
US5270323A (en) * | 1990-05-31 | 1993-12-14 | Pfizer Inc. | Method of treating impotence |
EP0667776A1 (en) * | 1992-11-04 | 1995-08-23 | Sepracor, Inc. | Methods and compositions of (+) doxazosin for the treatment of hypertension |
WO1994028721A1 (en) * | 1993-06-11 | 1994-12-22 | The Board Of Trustees Of The Leland Stanford Junior University | Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity |
US5543430A (en) * | 1994-10-05 | 1996-08-06 | Kaesemeyer; W. H. | Method and formulation of stimulating nitric oxide synthesis |
FR2774593B1 (fr) * | 1998-02-12 | 2000-05-05 | Philippe Gorny | Obtention d'un medicament destine a combattre les dysfonctions sexuelles feminines |
-
2000
- 2000-02-04 MX MXPA01007952A patent/MXPA01007952A/es unknown
- 2000-02-04 CA CA002361575A patent/CA2361575A1/en not_active Abandoned
- 2000-02-04 JP JP2000596929A patent/JP2002536325A/ja active Pending
- 2000-02-04 EP EP00911701A patent/EP1150669A4/en not_active Withdrawn
- 2000-02-04 WO PCT/US2000/002798 patent/WO2000045809A1/en not_active Application Discontinuation
- 2000-02-04 AU AU33560/00A patent/AU3356000A/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0745332A1 (en) * | 1995-06-01 | 1996-12-04 | N.V. Nutricia | Clinical nutritional composition |
WO1999062509A1 (en) * | 1998-06-01 | 1999-12-09 | Nitromed, Inc. | Endogenous nitric oxide synthesis under conditions of low oxygen tension |
Non-Patent Citations (1)
Title |
---|
See also references of WO0045809A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA2361575A1 (en) | 2000-08-10 |
EP1150669A1 (en) | 2001-11-07 |
AU3356000A (en) | 2000-08-25 |
MXPA01007952A (es) | 2004-03-26 |
WO2000045809A1 (en) | 2000-08-10 |
JP2002536325A (ja) | 2002-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1037303A1 (en) | Compositions and methods for treatment of mitochondrial diseases | |
HUP0301121A3 (en) | Topical pharmaceutical formulations and methods of treatment | |
EP1227821A4 (en) | THERAPEUTIC COMPOSITIONS AND METHOD FOR USE THEREOF | |
HK1048247A1 (en) | Stable carotene-xanthophyll beadlet compositions and methods of use | |
AU2072201A (en) | Agents and methods for the treatment of proliferative diseases | |
AU7880700A (en) | Compositions and methods of treatment for skin conditions using extracts of turmeric | |
AU7748000A (en) | Method and composition for the treatment of dermatologic diseases | |
KR100510795B1 (en) | Compositions and Methods for the Treatment of Tumor | |
AUPQ415899A0 (en) | Compositions for and methods of treatment of allergic diseases | |
AU3632600A (en) | Compositions and methods for the treatment of immune related diseases | |
HUP0302718A3 (en) | Methods and compositions for the treatment of diseases of the eye | |
IL143594A0 (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases | |
HUP0104963A3 (en) | Compositions for the treatment of skin diseases | |
EP1150669A4 (en) | FORMULATIONS ON L-ARGININE BASE FOR DISEASE TREATMENT AND USE THEREOF | |
GB9929497D0 (en) | Improved amino acid mixtures for the treatment and/or management of certain diseases | |
AU3434601A (en) | Compositions and methods for the treatment of immune related diseases | |
IL141551A0 (en) | Compositions and methods for the treatment of immune related diseases | |
EP1189584A4 (en) | CARE AND DERMATOLOGICAL COMPOSITION BASED ON ALPHA-AMINO ACID | |
AU2420101A (en) | Method and composition for the treatment of pain | |
EP1173189A4 (en) | ASIALOZYTOKINES AND TREATMENT OF LIVER DISEASES | |
AU2566201A (en) | Compounds and methods for the treatment of pain | |
GB9906808D0 (en) | Formulation for treatment of pain | |
IL150202A0 (en) | Method and composition for the treatment of pain | |
AU1621501A (en) | Methods and compositions for treatment of disease | |
AU2002313992A1 (en) | Compositions and Methods for Treatment of Mitochondrial Diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20010829 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ANGIOGENIX, INC. |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 61K 35/78 B Ipc: 7A 61K 31/505 B Ipc: 7A 61K 31/198 B Ipc: 7A 61K 31/495 B Ipc: 7A 61K 31/195 A |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20050503 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20060411 |